Clinical Trial Update: Atalante Exoskeleton in the Rehabilitation of Patients With Amyotrophic Lateral Sclerosis [NA]

View source ↗

Summary

A clinical trial update indicates the Atalante Exoskeleton study for rehabilitation in amyotrophic lateral sclerosis has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Atalante Exoskeleton

Snippet

Sponsor: Institut de Recherche sur la Moelle épinière et l'Encéphale | Conditions: ALS - Amyotrophic Lateral Sclerosis | NA | Status: SUSPENDED